Form 4: UnitedHealth Group Director Acquires Shares as Part of Compensation Plan

Sentiment:

SEC Form 4 Filing


John H. Noseworthy, a director at UnitedHealth Group, acquired 180 shares of common stock as part of his quarterly compensation for board service.

Summary

  • On April 1, 2025, John H. Noseworthy, a director of UnitedHealth Group, acquired 180 shares of common stock.
  • The acquisition was part of his regular quarterly compensation for serving as a director.
  • These shares are in the form of deferred stock units, which are immediately vested but must be retained until he completes his service on the Board.
  • Following the transaction, Noseworthy directly owns 5,763 shares of UnitedHealth Group common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a routine transaction related to director compensation, which is generally viewed as a positive sign of alignment between management and shareholders.

Positives

  • The acquisition of shares by a director demonstrates confidence in the company's future.
  • The structure of the deferred stock units aligns the director's interests with the long-term performance of the company.

Industry Context

Director compensation in the form of stock is a common practice in publicly traded companies to align the interests of board members with those of shareholders. This filing reflects standard compensation practices.

Comparison to Industry Standards

  • Stock grants to board members are a typical component of compensation packages across the healthcare industry.
  • Companies like CVS Health, Anthem (now Elevance Health), and Cigna also utilize stock-based compensation for their directors.
  • The amount of stock granted varies based on company size, performance, and board member responsibilities.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
  • There is no significant impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
04/01/2025Date of transaction: Acquisition of 180 shares of common stock.
04/03/2025Date of signature on the Form 4 filing.

Keywords

UnitedHealth Group, Director Compensation, Form 4, Stock Acquisition, Deferred Stock Units, UNH, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.